Prince Pharmaceutical Co., Ltd. (6935.TWO)
TWD 19.45
(2.1%)
TWD 19.45
(2.1%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 753.32 Million | 712.52 Million | 441.07 Million | 295.79 Million | 249.6 Million |
| Cost of Revenue | 600.23 Million | 506.73 Million | 315.58 Million | 206.81 Million | 182.01 Million |
| Gross Profit | 153.09 Million | 205.79 Million | 125.48 Million | 88.97 Million | 67.59 Million |
| Operating Expenses | 127.41 Million | 137.94 Million | 126.58 Million | 139.25 Million | -9.3 Million |
| Selling, General and Administrative Expenses | 72.74 Million | 65.9 Million | 47.37 Million | 61.14 Million | 48.35 Million |
| Research and Development Expenses | 54.67 Million | 72.04 Million | 79.2 Million | 78.21 Million | 28.54 Million |
| Other Expenses | - | 5.15 Million | -1.67 Million | 14.14 Million | -9.3 Million |
| Cost and Expenses | 727.64 Million | 644.68 Million | 442.17 Million | 346.07 Million | -9.3 Million |
| Operating Income | 25.68 Million | 73.22 Million | -2.73 Million | -50.27 Million | -9.3 Million |
| Interest Expense | 10.46 Million | 8.94 Million | 7.55 Million | 5.3 Million | 2.57 Million |
| Income Tax Expense | 3.85 Million | 12.64 Million | -2 Million | -7.64 Million | 5000.00 |
| Earnings before Tax | 19.16 Million | 64.2 Million | -10.3 Million | -41.44 Million | 14 Thousand |
| Net Income | 15.3 Million | 51.55 Million | -8.3 Million | -33.8 Million | 9000.00 |
| Earnings Per Share Basic | 0.42 | 1.55 | -0.25 | -1.03 | 0.00 |
| Earnings Per Share Diluted | 0.42 | 1.55 | -0.25 | -1.03 | 0.00 |
| Weighted Average Shares Outstanding | 36.45 Million | 33.19 Million | 33.19 Million | 32.72 Million | 32.05 Million |
| Weighted Average Shares Outstanding (Diluted) | 36.54 Million | 33.32 Million | 33.19 Million | 32.72 Million | 32.05 Million |
| Gross Margin | 0.20 | 0.29 | 0.28 | 0.30 | 0.27 |
| EBIT Margin | 0.12 | 0.18 | 0.10 | -0.03 | -0.04 |
| Profit Margin | 0.02 | 0.07 | -0.02 | -0.11 | 0.00 |
| EBITDA | 88.18 Million | 125.57 Million | 43.47 Million | -7.76 Million | -3000.00 |
| Earnings Before Tax Margin | 0.03 | 0.10 | -0.01 | -0.17 | -0.04 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 169.9 Million | 169.9 Million | 198.65 Million | 753.32 Million | 198.65 Million | 178 Million |
| Cost of Revenue | 151.01 Million | 151.01 Million | 156.26 Million | 600.23 Million | 156.26 Million | 143.85 Million |
| Gross Profit | 18.89 Million | 18.89 Million | 42.39 Million | 153.09 Million | 42.39 Million | 34.15 Million |
| Operating Expenses | 31.52 Million | 29.1 Million | 34.12 Million | 127.41 Million | 34.12 Million | 28.18 Million |
| Selling, General and Administrative Expenses | 18.61 Million | 18.61 Million | 19.46 Million | - | 19.46 Million | 16.85 Million |
| Research and Development Expenses | 12.91 Million | 12.91 Million | 15.24 Million | - | 15.24 Million | 12.08 Million |
| Other Expenses | - | - | - | 2.68 Million | - | - |
| Cost and Expenses | 182.54 Million | 180.12 Million | 190.38 Million | 727.64 Million | 190.38 Million | 172.04 Million |
| Operating Income | -12.63 Million | -12.63 Million | 7.67 Million | 29.52 Million | 7.67 Million | 5.21 Million |
| Interest Expense | - | - | - | 10.46 Million | - | - |
| Income Tax Expense | - | - | 1.21 Million | 3.85 Million | 1.21 Million | 714 Thousand |
| Earnings before Tax | -12.41 Million | -12.41 Million | 6.01 Million | 19.16 Million | 6.01 Million | 3.57 Million |
| Net Income | -12.41 Million | -12.41 Million | 4.79 Million | 15.3 Million | 4.79 Million | 2.85 Million |
| Earnings Per Share Basic | -0.34 | -0.34 | 0.13 | - | 0.13 | 0.08 |
| Earnings Per Share Diluted | -0.34 | -0.34 | 0.13 | - | 0.13 | 0.08 |
| Weighted Average Shares Outstanding | 36.51 Million | 36.51 Million | 37.29 Million | 36.45 Million | 37.29 Million | 35.7 Million |
| Weighted Average Shares Outstanding (Diluted) | 36.55 Million | 36.51 Million | 37.56 Million | 36.54 Million | 37.56 Million | 35.52 Million |
| Gross Margin | 0.11 | 0.11 | 0.21 | 0.20 | 0.21 | 0.19 |
| EBIT Margin | 0.00 | 0.02 | 0.10 | - | 0.10 | 0.10 |
| Profit Margin | -0.07 | -0.07 | 0.02 | 0.02 | 0.02 | 0.02 |
| EBITDA | 671 Thousand | 2.79 Million | 20.65 Million | - | 20.65 Million | 17.31 Million |
| Earnings Before Tax Margin | -0.07 | -0.07 | 0.04 | 0.04 | 0.04 | 0.03 |
CAA
ALUP11
3787
TAVERNIER
0HST
SAPMF